Age-related antibody response to Orthopoxviruses and implications for public health measures: Insights from a South Korean study
Kim Y, Kim G, Min G, Woo Y, Peck KR, Hong JJ, Kim SB.
Applications: ELISA
Reactive species: Human
"
Abstract: Background: After the eradication of smallpox, there have been no specific public health measures for any Orthopoxviruses (OPXVs). Therefore, it is necessary to countermeasure OPXV infections after Mpox (formerly monkeypox) occurrences, such as the latest global outbreak in 2022-2023. This study aimed to provide crucial insights for the development of effective public health policy making against mpox in populations residing in regions where the virus is not prevalent."
Article snippet: For antibody assessments, plasma was aliquoted and stored at -20 °C. Briefly, the 96-well plates (***) were coated with 100 ng/well of MPXV A29 protein (***) or
Variola cytokine response-modifying B (CrmB) protein (Creative Diagnostics, Shirley, NY, USA) overnight at 4 °C.
Figure 1. The concentration of antibodies that positively responded to the variola virus antigen cytokine response-modifying B protein.